North America
The method could be used to sequence DNA molecules that fall between short and long reads, but where high throughput and single-base accuracy are required.
FDA Warns of Potential False Positives With Abbott SARS-CoV-2 Molecular Tests
The agency said the issue could be related to current mixing parameters of the PCR reaction mixture resulting in overflow in wells of the reagent tray.
The technology has been licensed by MGeneRx, which plans to commercialize it in the US first, then expand to low- and middle-income countries.
In Brief This Week: Myriad Genetics, Danaher, Co-Diagnostics, and More
News items for the week of Sept. 13, 2021.
Polygenic Risk Scores for Breast, Prostate Cancer Adaptable for Cross-Ancestry Use, Study Shows
The researchers said the approach could be a short-term measure while genetic studies of more diverse ancestral populations are performed.
Sep 15, 2021